相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Symptomatic and Functional Improvement in Employed Depressed Patients A Double-Blind Clinical Trial of Desvenlafaxine Versus Placebo
Boadie W. Dunlop et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
An Integrated Analysis of the Efficacy of Desvenlafaxine Compared with Placebo in Patients with Major Depressive Disorder
Michael E. Thase et al.
CNS SPECTRUMS (2009)
An Integrated Analysis of the Safety and Tolerability of Desvenlafaxine Compared with Placebo in the Treatment of Major Depressive Disorder
Anita H. Clayton et al.
CNS SPECTRUMS (2009)
Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder
Michael R. Liebowitz et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial
Patrice Boyer et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder
Lucia Septien-Velez et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2007)
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT study
James H. Kocsis et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxiine succinate in the treatment of major depressive disorder
Nicolas A. DeMartinis et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
SNRIs: The pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants
SM Stahl et al.
CNS SPECTRUMS (2005)
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
MJ Detke et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2004)
Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose
GK Isbister et al.
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2004)
The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R).
RC Kessler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
What clinicians should know about the QT interval
SM Al-Khatib et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
How to correct the QT interval for the effects of heart rate in clinical studies
P Davey
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2002)
Treatment non-adherence in affective disorders
R Lingam et al.
ACTA PSYCHIATRICA SCANDINAVICA (2002)
Antidepressant-associated mania and psychosis resulting in psychiatric admissions
A Preda et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
分享论文
